Bios Clinical — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
SIRPant Immunotherapeutics, Inc.Jan 2024SEC filingmedium confidence
Hummelstown, US
Board seatJohn Fucci· per SEC Form D · $42.1M raise · filed Jan 2024
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.